Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionSUMO ligase activity

RGPD2 RGPD8 RGPD1

6.47e-0520793GO:0061665
GeneOntologyMolecularFunctiontRNA (cytidine-3-)-methyltransferase activity

METTL2A METTL2B

9.23e-054792GO:0052735
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

RGPD2 RGPD8 TRIO KALRN LARS1 RGPD1 VAV3 HERC2 RGPD5

1.74e-04507799GO:0060589
GeneOntologyMolecularFunctionGTPase regulator activity

RGPD2 RGPD8 TRIO KALRN LARS1 RGPD1 VAV3 HERC2 RGPD5

1.74e-04507799GO:0030695
GeneOntologyMolecularFunctionenzyme activator activity

RGPD2 MMP24 ABI1 FN1 RGPD8 LARS1 RGPD1 RICTOR VAV3 RGPD5

2.56e-046567910GO:0008047
GeneOntologyMolecularFunctionSUMO transferase activity

RGPD2 RGPD8 RGPD1

3.87e-0436793GO:0019789
GeneOntologyMolecularFunctionenzyme regulator activity

RGPD2 MMP24 ABI1 FN1 RGPD8 TRIO KALRN LARS1 RGPD1 RICTOR VAV3 ADGRV1 HERC2 ITIH2 RGPD5

3.92e-0414187915GO:0030234
GeneOntologyMolecularFunctioncell adhesion molecule binding

MMP24 MYH9 ABI1 TRIM25 FN1 ACTN2 DMD DHX29 ITGB8

5.88e-04599799GO:0050839
GeneOntologyMolecularFunctionintegrin binding

MYH9 FN1 ACTN2 DMD ITGB8

6.52e-04175795GO:0005178
GeneOntologyMolecularFunctionstructural constituent of muscle

SORBS2 ACTN2 DMD

6.56e-0443793GO:0008307
GeneOntologyMolecularFunctiontRNA (cytidine) methyltransferase activity

METTL2A METTL2B

6.81e-0410792GO:0016427
GeneOntologyMolecularFunctionmedium-chain fatty acid-CoA ligase activity

ACSL3 ACSM5

8.31e-0411792GO:0031956
GeneOntologyMolecularFunctionGTPase activator activity

RGPD2 RGPD8 LARS1 RGPD1 VAV3 RGPD5

8.35e-04279796GO:0005096
GeneOntologyMolecularFunctionpeptidyl-prolyl cis-trans isomerase activity

RGPD2 RGPD8 RGPD1

1.02e-0350793GO:0003755
GeneOntologyMolecularFunctioncis-trans isomerase activity

RGPD2 RGPD8 RGPD1

1.21e-0353793GO:0016859
GeneOntologyBiologicalProcessNLS-bearing protein import into nucleus

RGPD2 RGPD8 RGPD1 RGPD5

9.70e-0720804GO:0006607
GeneOntologyBiologicalProcesspositive regulation of glucokinase activity

RGPD2 RGPD8 RGPD1

4.64e-069803GO:0033133
GeneOntologyBiologicalProcesspositive regulation of hexokinase activity

RGPD2 RGPD8 RGPD1

6.61e-0610803GO:1903301
GeneOntologyBiologicalProcessregulation of glucokinase activity

RGPD2 RGPD8 RGPD1

1.56e-0513803GO:0033131
GeneOntologyBiologicalProcessregulation of hexokinase activity

RGPD2 RGPD8 RGPD1

1.98e-0514803GO:1903299
GeneOntologyCellularComponentcytoplasmic periphery of the nuclear pore complex

RGPD2 RGPD8 RGPD1

2.87e-068793GO:1990723
GeneOntologyCellularComponentnuclear pore cytoplasmic filaments

RGPD2 RGPD8 RGPD1

6.12e-0610793GO:0044614
GeneOntologyCellularComponentannulate lamellae

RGPD2 RGPD8 RGPD1

1.84e-0514793GO:0005642
GeneOntologyCellularComponentlamellipodium

DPP4 MYH9 SORBS2 ABI1 ABI2 DMD DUSP22

2.64e-05230797GO:0030027
GeneOntologyCellularComponentnuclear pore nuclear basket

RGPD2 RGPD8 RGPD1

4.07e-0518793GO:0044615
GeneOntologyCellularComponentmyosin II filament

MYH9 MYH14

4.22e-053792GO:0097513
GeneOntologyCellularComponentnuclear inclusion body

RGPD2 RGPD8 RGPD1

5.65e-0520793GO:0042405
GeneOntologyCellularComponentSUMO ligase complex

RGPD2 RGPD8 RGPD1

6.58e-0521793GO:0106068
GeneOntologyCellularComponentfilopodium

ABI1 UBE2Q1 ABI2 ACTN2 DMD

1.03e-04123795GO:0030175
GeneOntologyCellularComponentZ disc

SORBS2 GRK3 ACTN2 FBXO32 DMD

2.70e-04151795GO:0030018
GeneOntologyCellularComponentI band

SORBS2 GRK3 ACTN2 FBXO32 DMD

4.17e-04166795GO:0031674
GeneOntologyCellularComponentnuclear body

CREBRF MYH9 TRIM25 PRPF4 CTR9 MORF4L1 CENPI LARS1 RO60 ICE1 CHD3

5.66e-049037911GO:0016604
GeneOntologyCellularComponentnuclear pore

RGPD2 RGPD8 RGPD1 RGPD5

5.84e-04101794GO:0005643
GeneOntologyCellularComponentcell leading edge

DPP4 MYH9 SORBS2 ABI1 ABI2 ADGRV1 DMD DUSP22

5.97e-04500798GO:0031252
GeneOntologyCellularComponentactin-based cell projection

ABI1 UBE2Q1 ABI2 ACTN2 ADGRV1 DMD

6.47e-04278796GO:0098858
GeneOntologyCellularComponentSCAR complex

ABI1 ABI2

9.08e-0412792GO:0031209
GeneOntologyCellularComponentsupramolecular fiber

KRT10 MYH9 SORBS2 GRK3 ABI2 MYH14 ASPM ACTN2 FBXO32 DMD KRT79 DUSP22

1.51e-0311797912GO:0099512
GeneOntologyCellularComponentsupramolecular polymer

KRT10 MYH9 SORBS2 GRK3 ABI2 MYH14 ASPM ACTN2 FBXO32 DMD KRT79 DUSP22

1.60e-0311877912GO:0099081
GeneOntologyCellularComponentactin filament

MYH9 ABI2 ACTN2 DUSP22

2.29e-03146794GO:0005884
GeneOntologyCellularComponentpostsynaptic actin cytoskeleton

ABI2 ACTN2

2.31e-0319792GO:0098871
GeneOntologyCellularComponentsarcomere

SORBS2 GRK3 ACTN2 FBXO32 DMD

2.54e-03249795GO:0030017
GeneOntologyCellularComponentfilopodium tip

ABI1 ABI2

2.56e-0320792GO:0032433
GeneOntologyCellularComponentperinuclear region of cytoplasm

ACSL3 RGPD2 SORBS2 GRK3 RGPD8 KALRN RGPD1 UPF1 ADGRV1 DMD

2.66e-039347910GO:0048471
GeneOntologyCellularComponentmyofibril

SORBS2 GRK3 ACTN2 FBXO32 DMD

3.76e-03273795GO:0030016
GeneOntologyCellularComponentmyosin filament

MYH9 MYH14

4.00e-0325792GO:0032982
GeneOntologyCellularComponentpostsynaptic cytoskeleton

ABI2 ACTN2

4.32e-0326792GO:0099571
MousePhenofailure of blastocyst formation

POMT2 RGPD2 RGPD8 RGPD1

1.01e-0531624MP:0012129
MousePhenoabnormal blastocyst formation

POMT2 RGPD2 RGPD8 RGPD1

2.57e-0539624MP:0012128
MousePhenoelevated level of mitotic sister chromatid exchange

RGPD2 RGPD8 RGPD1

4.47e-0516623MP:0003701
DomainGrip

RGPD2 RGPD8 RGPD1 RGPD5

8.17e-0811764SM00755
DomainGRIP

RGPD2 RGPD8 RGPD1 RGPD5

8.17e-0811764PF01465
DomainRan_BP1

RGPD2 RGPD8 RGPD1 RGPD5

1.22e-0712764PF00638
DomainGRIP_dom

RGPD2 RGPD8 RGPD1 RGPD5

1.22e-0712764IPR000237
DomainGRIP

RGPD2 RGPD8 RGPD1 RGPD5

1.22e-0712764PS50913
DomainRANBD1

RGPD2 RGPD8 RGPD1 RGPD5

1.22e-0712764PS50196
DomainRanBD

RGPD2 RGPD8 RGPD1 RGPD5

1.76e-0713764SM00160
DomainRan_bind_dom

RGPD2 RGPD8 RGPD1 RGPD5

1.76e-0713764IPR000156
DomainSpectrin

TRIO KALRN ACTN2 DMD

2.11e-0623764PF00435
DomainGCC2_Rab_bind

RGPD2 RGPD8 RGPD1

2.24e-067763IPR032023
DomainRab_bind

RGPD2 RGPD8 RGPD1

2.24e-067763PF16704
DomainSpectrin_repeat

TRIO KALRN ACTN2 DMD

5.57e-0629764IPR002017
Domain-

RGPD2 RGPD8 RGPD1

7.61e-06107631.10.220.60
DomainSpectrin/alpha-actinin

TRIO KALRN ACTN2 DMD

8.35e-0632764IPR018159
DomainSPEC

TRIO KALRN ACTN2 DMD

8.35e-0632764SM00150
DomainSH3

SORBS2 ABI1 TRIO KALRN ABI2 VAV3 TXK

2.79e-05216767SM00326
DomainSH3

SORBS2 ABI1 TRIO KALRN ABI2 VAV3 TXK

2.79e-05216767PS50002
DomainSH3_domain

SORBS2 ABI1 TRIO KALRN ABI2 VAV3 TXK

3.14e-05220767IPR001452
DomainAbl-interactor_HHR_dom

ABI1 ABI2

4.89e-053762IPR012849
DomainAbi_HHR

ABI1 ABI2

4.89e-053762PF07815
DomainSH3_1

SORBS2 ABI1 TRIO ABI2 VAV3 TXK

5.50e-05164766PF00018
DomainMyosin-like_IQ_dom

MYH9 MYH14 ASPM

5.99e-0519763IPR027401
Domain-

MYH9 MYH14 ASPM

5.99e-05197634.10.270.10
DomainMeTrfase

METTL2A METTL2B

9.75e-054762IPR026113
DomainCH

ASPM VAV3 ACTN2 DMD

1.42e-0465764SM00033
DomainCH

ASPM VAV3 ACTN2 DMD

1.89e-0470764PF00307
Domain-

ASPM VAV3 ACTN2 DMD

2.00e-04717641.10.418.10
DomainCH

ASPM VAV3 ACTN2 DMD

2.23e-0473764PS50021
DomainMethyltransf_12

METTL2A METTL2B

2.43e-046762PF08242
DomainMethyltransf_12

METTL2A METTL2B

2.43e-046762IPR013217
DomainCH-domain

ASPM VAV3 ACTN2 DMD

2.47e-0475764IPR001715
DomainPH_dom-like

RGPD2 GRK3 RGPD8 TRIO KALRN RGPD1 VAV3 RGPD5

3.33e-04426768IPR011993
DomainCAMSAP_CH

ASPM VAV3

3.39e-047762PF11971
DomainCAMSAP_CH

ASPM VAV3

3.39e-047762IPR022613
DomainTPR-contain_dom

RGPD2 RGPD8 CTR9 RGPD1 RGPD5

3.65e-04150765IPR013026
DomainTPR-like_helical_dom

RGPD2 RGPD8 CTR9 RGPD1 CSTF3 RGPD5

3.73e-04233766IPR011990
DomainCalx_beta

FRAS1 ADGRV1

4.50e-048762SM00237
DomainTPR_1

RGPD8 CTR9 RGPD1 RGPD5

4.96e-0490764PF00515
DomainTPR_1

RGPD8 CTR9 RGPD1 RGPD5

4.96e-0490764IPR001440
DomainTPR_REGION

RGPD2 RGPD8 CTR9 RGPD1 RGPD5

5.64e-04165765PS50293
DomainTPR

RGPD2 RGPD8 CTR9 RGPD1 RGPD5

5.64e-04165765PS50005
DomainCalx_beta

FRAS1 ADGRV1

5.77e-049762IPR003644
DomainCalx-beta

FRAS1 ADGRV1

5.77e-049762PF03160
DomainIL6Ra-bind

IL13RA1 IL2RG

8.78e-0411762PF09240
DomainTypeI_recpt_CBD

IL13RA1 IL2RG

8.78e-0411762IPR015321
Domain-

RGPD2 GRK3 RGPD8 TRIO KALRN RGPD1 VAV3

1.06e-033917672.30.29.30
Domain-

RGPD2 RGPD8 CTR9 RGPD1 CSTF3

1.56e-032077651.25.40.10
DomainMyosin_N

MYH9 MYH14

1.66e-0315762PF02736
DomainMyosin_N

MYH9 MYH14

1.66e-0315762IPR004009
DomainTPR

RGPD2 RGPD8 CTR9 RGPD1

1.90e-03129764SM00028
DomainTPR_repeat

RGPD2 RGPD8 CTR9 RGPD1

2.12e-03133764IPR019734
DomainDH_1

TRIO KALRN VAV3

2.16e-0363763PS00741
DomainRUN

RUNDC3B SNX29

2.40e-0318762SM00593
DomainMyosin_tail_1

MYH9 MYH14

2.40e-0318762PF01576
DomainZZ

HERC2 DMD

2.40e-0318762PF00569
DomainMyosin_tail

MYH9 MYH14

2.40e-0318762IPR002928
DomainZF_ZZ_2

HERC2 DMD

2.40e-0318762PS50135
DomainZF_ZZ_1

HERC2 DMD

2.40e-0318762PS01357
DomainRUN

RUNDC3B SNX29

2.67e-0319762PS50826
DomainZnf_ZZ

HERC2 DMD

2.67e-0319762IPR000433
DomainRUN

RUNDC3B SNX29

2.67e-0319762PF02759
DomainRun_dom

RUNDC3B SNX29

2.67e-0319762IPR004012
DomainZnF_ZZ

HERC2 DMD

2.67e-0319762SM00291
DomainRhoGEF

TRIO KALRN VAV3

2.68e-0368763SM00325
DomainRhoGEF

TRIO KALRN VAV3

2.91e-0370763PF00621
DomainDH_2

TRIO KALRN VAV3

2.91e-0370763PS50010
DomainIQ

MYH9 MYH14 ASPM

3.03e-0371763PF00612
DomainDH-domain

TRIO KALRN VAV3

3.03e-0371763IPR000219
Domain-

TRIO KALRN VAV3

3.03e-03717631.20.900.10
DomainCRAL_TRIO

TRIO KALRN

3.26e-0321762PF00650
DomainActinin_actin-bd_CS

ACTN2 DMD

3.91e-0323762IPR001589
Domain-

TRIO KALRN

3.91e-03237623.40.525.10
DomainACTININ_2

ACTN2 DMD

3.91e-0323762PS00020
DomainACTININ_1

ACTN2 DMD

3.91e-0323762PS00019
PathwayREACTOME_RHO_GTPASE_EFFECTORS

RGPD2 MYH9 ABI1 RGPD8 ABI2 MYH14 CENPI RGPD1

1.78e-05257638MM14755
PathwayPID_RAC1_REG_PATHWAY

ABI1 TRIO KALRN VAV3

2.39e-0538634M241
PathwayKEGG_REGULATION_OF_ACTIN_CYTOSKELETON

MYH9 FN1 ABI2 MYH14 VAV3 ACTN2 ITGB8

4.40e-05213637M18306
PathwayBIOCARTA_RANBP2_PATHWAY

RGPD2 RGPD8 RGPD1

6.62e-0518633MM1549
PathwayREACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3

RGPD2 MYH9 ABI1 RGPD8 TRIO KALRN ABI2 MYH14 CENPI RGPD1 VAV3

1.25e-046496311MM15690
PathwayREACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS

MYH9 ABI1 IGHV3-7 ABI2 VAV3

1.53e-04114635MM14814
PathwayREACTOME_PARASITE_INFECTION

MYH9 ABI1 IGHV3-7 ABI2 VAV3

1.66e-04116635M29843
PathwayREACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS

MYH9 ABI1 IGHV3-7 ABI2 VAV3

4.39e-04143635M27107
PathwayREACTOME_GLUCOSE_METABOLISM

RGPD2 RGPD8 RGPD1 PGM2L1

4.88e-0482634MM15394
PathwayREACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS

RGPD2 RGPD8 RGPD1 HERC2

5.35e-0484634MM14929
PathwayREACTOME_RAC2_GTPASE_CYCLE

ABI1 TRIO ABI2 VAV3

6.11e-0487634MM15600
PathwayREACTOME_RAC2_GTPASE_CYCLE

ABI1 TRIO ABI2 VAV3

6.38e-0488634M41810
PathwayREACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY

RGPD2 RGPD8 RGPD1

7.47e-0440633MM14945
PathwayREACTOME_EPH_EPHRIN_SIGNALING

MYH9 KALRN MYH14 VAV3

7.54e-0492634M27201
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS

RGPD2 RGPD8 RGPD1

8.03e-0441633MM15200
PathwayREACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS

RGPD2 RGPD8 RGPD1

8.62e-0442633MM15039
PathwayREACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA

RGPD2 RGPD8 RGPD1

9.24e-0443633MM14609
PathwayREACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES

RGPD2 RGPD8 CENPI RGPD1

1.03e-03100634MM14561
PathwayREACTOME_RAC1_GTPASE_CYCLE

ABI1 TRIO KALRN ABI2 VAV3

1.09e-03175635MM15599
PathwayREACTOME_SIGNALING_BY_VEGF

ABI1 ABI2 RICTOR VAV3

1.15e-03103634MM14752
PathwayREACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS

RGPD2 RGPD8 RGPD1

1.20e-0347633MM14939
PathwayREACTOME_SIGNALING_BY_VEGF

ABI1 ABI2 RICTOR VAV3

1.28e-03106634M27077
PathwayREACTOME_GENE_SILENCING_BY_RNA

RGPD2 RGPD8 RGPD1

1.35e-0349633MM14837
PathwayREACTOME_RAC1_GTPASE_CYCLE

ABI1 TRIO KALRN ABI2 VAV3

1.37e-03184635M41809
PathwayREACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS

RGPD2 RGPD8 RGPD1

1.44e-0350633MM14610
PathwayREACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS

RGPD2 RGPD8 RGPD1

1.52e-0351633MM15151
Pubmed

Complex genomic rearrangements lead to novel primate gene function.

RGPD2 RGPD8 RGPD1 RGPD5

9.03e-10780415710750
Pubmed

Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.

ACSL3 RGPD2 MYH9 RGPD8 RGPD1 RICTOR UPF1 DHX29 RGPD5

1.77e-0921580935973513
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

KRT10 MYH9 SORBS2 ABI1 TRIM25 FN1 TRIO KALRN MYH14 LARS1 SMURF1 CHD3 ACTN2 UPF1 DMD KRT79 DHX29

2.20e-081431801737142655
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

KRT10 MYH9 TRIM25 TRIO MYH14 RICTOR ICE1 HERC2

2.28e-0820280833005030
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

CREBRF ACSL3 RGPD2 KRT10 MYH9 RGPD8 MYH14 CTR9 RGPD1 ASPM NFXL1 CHD3 ACTN2 DMD MAPK6 KRT79 RGPD5

2.46e-081442801735575683
Pubmed

The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.

ACSL3 KRT10 MYH9 SORBS2 TRIM25 TRIO LARS1 CHD3 DMD

3.00e-0829880930737378
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

ACSL3 MYH9 TRIM25 FN1 UTP15 MYH14 CTR9 UBTF LARS1 ASPM NFXL1 RICTOR UPF1 HERC2 PLOD1 DHX29

6.49e-081353801629467282
Pubmed

Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.

ABI1 ABI2 MYH14 IL2RG

1.84e-072280430089695
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

ACSL3 FRAS1 TRIM25 UTP15 CTR9 UBTF ASPM NFXL1 PON2 RICTOR UPF1 HERC2 PLOD1 DHX29 SNX29 DMXL1

2.33e-071487801633957083
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

RGPD2 MYH9 SORBS2 ABI1 RGPD8 TRIO KALRN ABI2 MORF4L1 RGPD1 UPF1 HERC2 UNC79

2.95e-07963801328671696
Pubmed

Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.

RGPD2 RGPD8 RGPD1

4.07e-07780321205196
Pubmed

Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.

RGPD2 RGPD8 RGPD1

4.07e-07780318949001
Pubmed

Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.

RGPD2 RGPD8 RGPD1

4.07e-07780325187515
Pubmed

Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.

RGPD2 RGPD8 RGPD1

4.07e-0778039037092
Pubmed

Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.

RGPD2 RGPD8 RGPD1

4.07e-0778038603673
Pubmed

Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).

RGPD2 RGPD8 RGPD1

4.07e-07780326632511
Pubmed

Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

RGPD2 RGPD8 RGPD1

4.07e-07780324403063
Pubmed

Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.

RGPD2 RGPD8 RGPD1

4.07e-07780323818861
Pubmed

Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.

RGPD2 RGPD8 RGPD1

4.07e-07780311353387
Pubmed

Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.

RGPD2 RGPD8 RGPD1

4.07e-07780330944974
Pubmed

Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.

RGPD2 RGPD8 RGPD1

4.07e-07780338838144
Pubmed

Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.

RGPD2 RGPD8 RGPD1

4.07e-07780323536549
Pubmed

Retina-specifically expressed novel subtypes of bovine cyclophilin.

RGPD2 RGPD8 RGPD1

4.07e-0778037559465
Pubmed

Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.

RGPD2 RGPD8 RGPD1

4.07e-07780317372272
Pubmed

Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.

RGPD2 RGPD8 RGPD1

4.07e-07780338657106
Pubmed

Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.

RGPD2 RGPD8 RGPD1

4.07e-07780312191015
Pubmed

Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

RGPD2 RGPD8 RGPD1

4.07e-07780322821000
Pubmed

Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.

RGPD2 RGPD8 RGPD1

4.07e-07780320682751
Pubmed

The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.

RGPD2 RGPD8 RGPD1

6.51e-07880322262462
Pubmed

The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.

RGPD2 RGPD8 RGPD1

6.51e-07880321670213
Pubmed

Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.

RGPD2 RGPD8 RGPD1

6.51e-07880328745977
Pubmed

Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.

RGPD2 RGPD8 RGPD1

6.51e-07880327412403
Pubmed

Mice lacking Ran binding protein 1 are viable and show male infertility.

RGPD2 RGPD8 RGPD1

6.51e-07880321310149
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

TRIM25 MYH14 CTR9 UBTF RICTOR UPF1 HERC2 PLOD1 DHX29

8.02e-0744080934244565
Pubmed

Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.

RGPD2 RGPD8 RGPD1

9.75e-07980318394993
Pubmed

The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.

RGPD2 RGPD8 RGPD1

9.75e-07980311553612
Pubmed

The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.

RGPD2 RGPD8 RGPD1

9.75e-07980310601307
Pubmed

The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.

RGPD2 RGPD8 RGPD1

9.75e-0798039733766
Pubmed

Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.

RGPD2 RGPD8 RGPD1

9.75e-07980328100513
Pubmed

Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.

RGPD2 RGPD8 RGPD1

9.75e-07980328877029
Pubmed

Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.

RGPD2 RGPD8 RGPD1

9.75e-07980317887960
Pubmed

Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.

RGPD2 RGPD8 RGPD1

1.39e-06108038857542
Pubmed

The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.

RGPD2 RGPD8 RGPD1

1.39e-061080327160050
Pubmed

Parkin ubiquitinates and promotes the degradation of RanBP2.

RGPD2 RGPD8 RGPD1

1.39e-061080316332688
Pubmed

Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.

RGPD2 RGPD8 RGPD1

1.39e-061080321859863
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

MYH9 PRPF4 MYH14 CENPI CHD3 HERC2 DHX29

1.85e-0625080733536335
Pubmed

An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.

RGPD2 RGPD8 RGPD1

1.91e-061180335771867
Pubmed

RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.

RGPD2 RGPD8 RGPD1

1.91e-061180317069463
Pubmed

T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.

RGPD2 RGPD8 RGPD1

1.91e-061180334110283
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

KRT10 ABI1 FN1 TRIO KALRN MYH14 MORF4L1 ACTN2 FBXO32

2.18e-0649780923414517
Pubmed

Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.

RGPD2 RGPD8 RGPD1

3.30e-061380331427429
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

ACSL3 MYH9 TRIM25 TRIO UTP15 PRPF4 MYH14 CTR9 UBTF LARS1 CSTF3 RO60 UPF1 DHX29

4.23e-061425801430948266
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

ACSL3 TRIO PRPF4 ABI2 CTR9 UBTF CSTF3 RICTOR HERC2 DMD PLOD1 DUSP22

4.86e-061049801227880917
Pubmed

Role for the Abi/wave protein complex in T cell receptor-mediated proliferation and cytoskeletal remodeling.

ABI1 ABI2

5.23e-06280216401422
Pubmed

Possible involvement of crosstalk cell-adhesion mechanism by endometrial CD26/dipeptidyl peptidase IV and embryonal fibronectin in human blastocyst implantation.

DPP4 FN1

5.23e-06280216621928
Pubmed

Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable.

ACTN2 DMD

5.23e-06280212140183
Pubmed

The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia.

ABI1 ABI2

5.23e-06280211516653
Pubmed

A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation.

DMD IL2RG

5.23e-06280223606600
Pubmed

Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors.

DMD IL2RG

5.23e-06280229700358
Pubmed

Distinct roles of nonmuscle myosin II isoforms for establishing tension and elasticity during cell morphodynamics.

MYH9 MYH14

5.23e-06280234374341
Pubmed

Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.

TRIO KALRN

5.23e-06280226858404
Pubmed

Patterning and folding of intestinal villi by active mesenchymal dewetting.

MYH9 FN1 MYH14

5.23e-061580338781967
Pubmed

Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.

RGPD2 RGPD8 RGPD1

5.23e-061580314697343
Pubmed

HENA, heterogeneous network-based data set for Alzheimer's disease.

TRIO ACTN2 HERC2 DMD RGPD5

8.79e-0612080531413325
Pubmed

TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target.

MYH9 TRIM25 HERC2

9.33e-061880334729304
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

ACSL3 RGPD2 MYH9 SORBS2 ABI1 RGPD8 TRIO KALRN ABI2 RGPD1 RICTOR DHX29

1.11e-051139801236417873
Pubmed

The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

POMT2 KRT10 MYH9 PRPF4 MYH14 CTR9 UBTF LARS1 RO60 CHD3 KRT79 DHX29

1.26e-051153801229845934
Pubmed

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

KRT10 MYH9 TRIM25 RGPD8 MYH14 UBTF UPF1 HERC2 RGPD5

1.39e-0562680933644029
Pubmed

EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway.

KRT10 MYH9 UPF1

1.51e-052180333029523
Pubmed

Regulation of cell-cell adhesion by Abi/Diaphanous complexes.

ABI1 ABI2

1.57e-05380219158278
Pubmed

Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis.

MYH9 MYH14

1.57e-05380215774463
Pubmed

Synaptic Kalirin-7 and Trio Interactomes Reveal a GEF Protein-Dependent Neuroligin-1 Mechanism of Action.

TRIO KALRN

1.57e-05380231801062
Pubmed

In search of a function for the E3B1/Abi2/Argbp1/NESH family (Review).

ABI1 ABI2

1.57e-05380212011975
Pubmed

Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy.

RICTOR DMD

1.57e-05380219046572
Pubmed

Planar polarity of multiciliated ependymal cells involves the anterior migration of basal bodies regulated by non-muscle myosin II.

MYH9 MYH14

1.57e-05380220685736
Pubmed

The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma.

TRIO VAV3

1.57e-05380219008376
Pubmed

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.

ACTN2 FBXO32

1.57e-05380215489953
Pubmed

Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family.

MYH9 MYH14

1.57e-05380214594953
Pubmed

Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy.

DMD IL2RG

1.57e-05380238438561
Pubmed

Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.

MYH9 MYH14

1.57e-05380215177565
Pubmed

Characterization of three full-length human nonmuscle myosin II paralogs.

MYH9 MYH14

1.57e-05380224072716
Pubmed

Identification of a novel type I cytokine receptor CRL2 preferentially expressed by human dendritic cells and activated monocytes.

IL13RA1 IL2RG

1.57e-05380211237741
Pubmed

ANKRD1 aggravates renal ischaemia‒reperfusion injury via promoting TRIM25-mediated ubiquitination of ACSL3.

ACSL3 TRIM25

1.57e-05380239285846
Pubmed

DALRD3 encodes a protein mutated in epileptic encephalopathy that targets arginine tRNAs for 3-methylcytosine modification.

METTL2A METTL2B

1.57e-05380232427860
Pubmed

Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C.

MYH9 MYH14

1.57e-05380215845534
Pubmed

Human pluripotent stem cell-derived myogenic progenitors undergo maturation to quiescent satellite cells upon engraftment.

DMD IL2RG

1.57e-05380235395188
Pubmed

Terminal differentiation of cortical neurons rapidly remodels RanGAP-mediated nuclear transport system.

RGPD2 RGPD8 RGPD1

1.75e-052280327717094
Pubmed

∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.

ACSL3 RGPD2 MYH9 MYH14 UBTF RGPD1 ACTN2 UPF1 ITIH2

1.81e-0564780926618866
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

ACSL3 FRAS1 MYH9 CTR9 CSTF3 CHD3 UPF1 PLOD1 SCAF4

1.94e-0565380933742100
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

ACSL3 MYH9 FN1 UTP15 MYH14 UBTF UPF1 HERC2 PLOD1

1.94e-0565380922586326
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

DPP4 MMP24 MYH9 ABI1 FN1 KALRN MYH14 SMURF1 ADGRV1 PLOD1 ITGB8

2.08e-051016801119056867
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

MYH9 TRIM25 UTP15 PRPF4 CTR9 UBTF CSTF3 UPF1 PLOD1

2.11e-0566080932780723
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

ACSL3 TRIM25 PRPF4 MYH14 UBTF LARS1 CSTF3 CHD3 HERC2 PLOD1 SCAF4

2.24e-051024801124711643
Pubmed

Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.

RGPD2 KRT10 ABI1 RGPD8 CTR9 LARS1 RGPD1 ACTN2 UPF1

2.24e-0566580930457570
Pubmed

A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.

RGPD2 RGPD8 UBTF MORF4L1 RGPD1

2.27e-0514680523892456
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

ACSL3 RGPD2 MYH9 TRIM25 RGPD8 MYH14 RGPD1 CHD3 DMD RGPD5

2.39e-05844801025963833
Pubmed

Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping.

MYH9 MYH14

3.13e-05480218697221
Pubmed

Abl interactor 1 (Abi-1) wave-binding and SNARE domains regulate its nucleocytoplasmic shuttling, lamellipodium localization, and wave-1 levels.

ABI1 ABI2

3.13e-05480215143189
Pubmed

Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system.

ABI1 ABI2

3.13e-05480210995551
Pubmed

Functional skeletal muscle regeneration from differentiating embryonic stem cells.

DMD IL2RG

3.13e-05480218204461
InteractionRGPD4 interactions

RGPD2 RGPD8 RGPD1 RICTOR RGPD5

2.03e-0822795int:RGPD4
InteractionRGPD2 interactions

RGPD2 RGPD8 RGPD1 RICTOR RGPD5

6.14e-0827795int:RGPD2
InteractionRGPD5 interactions

RGPD2 TRIM25 RGPD8 ABI2 RGPD1 RICTOR RGPD5

9.77e-0896797int:RGPD5
InteractionRGPD3 interactions

RGPD2 RGPD8 RGPD1 RICTOR RGPD5

1.10e-0647795int:RGPD3
InteractionRGPD1 interactions

RGPD2 RGPD8 RGPD1 RICTOR RGPD5

1.36e-0649795int:RGPD1
InteractionLRRC31 interactions

KRT10 MYH9 TRIM25 TRIO MYH14 RICTOR ICE1 HERC2

1.41e-06205798int:LRRC31
InteractionCSTL1 interactions

FRAS1 FN1 UBE2Q1 ADGRV1 ITIH2

3.17e-0658795int:CSTL1
InteractionHNRNPA1 interactions

DPP4 KRT10 MYH9 TRIM25 FN1 PRPF4 SMURF1 CSTF3 RO60 CHD3 UPF1 FBXO32 KRT79 PLOD1 SCAF4

3.37e-069457915int:HNRNPA1
InteractionACTN4 interactions

DPP4 MYH9 SORBS2 TRIM25 FN1 KDM4C UBTF RICTOR RO60 ACTN2

3.61e-064007910int:ACTN4
InteractionSPTBN1 interactions

DPP4 MYH9 TRIM25 FN1 KALRN LARS1 SMURF1 RICTOR CHD3 HERC2

5.67e-064217910int:SPTBN1
InteractionSIRT6 interactions

TRIM25 RGPD8 MYH14 CTR9 UBTF RICTOR CHD3 UPF1 HERC2 PLOD1 DHX29 RGPD5

5.74e-066287912int:SIRT6
InteractionDISC1 interactions

FN1 RGPD8 TRIO KALRN ABI2 ACTN2 HERC2 DMD SNX29 RGPD5

6.69e-064297910int:DISC1
InteractionMYL6 interactions

DPP4 MYH9 TRIM25 FN1 MYH14 RICTOR CHD3 FBXO32

7.08e-06255798int:MYL6
InteractionRICTOR interactions

ACSL3 RGPD2 KRT10 MYH9 TRIM25 RGPD8 LARS1 RGPD1 RICTOR UPF1 MAPK6 DHX29 RGPD5

7.36e-067597913int:RICTOR
InteractionPSMD2 interactions

MYH9 TRIM25 RGPD8 PRPF4 SMURF1 RICTOR FBXO32 HERC2 MAPK6 RGPD5

7.55e-064357910int:PSMD2
InteractionRPL22 interactions

MYH9 TRIM25 FN1 UBTF LARS1 SMURF1 CHD3 FBXO32 HERC2 DHX29

8.34e-064407910int:RPL22
InteractionRGPD8 interactions

RGPD2 RGPD8 RGPD1 RICTOR RGPD5

1.06e-0574795int:RGPD8
InteractionPSMC5 interactions

MYH9 TRIM25 RGPD8 UBE2Q1 ASPM SMURF1 RO60 FBXO32 MAPK6 RGPD5

1.90e-054847910int:PSMC5
InteractionSIPA1 interactions

MYH9 TRIM25 FN1 HERC2

1.98e-0541794int:SIPA1
InteractionOTUD6B interactions

MYH9 MYH14 SMURF1 CHD3 DHX29

2.09e-0585795int:OTUD6B
InteractionCHMP4B interactions

ACSL3 MYH9 SORBS2 UTP15 MYH14 UBTF RICTOR ACTN2 UPF1 HERC2 PLOD1 TXK

2.48e-057277912int:CHMP4B
InteractionCMA1 interactions

FRAS1 PON2 ADGRV1 ITIH2

3.15e-0546794int:CMA1
InteractionFGFR1OP2 interactions

ABI1 RGPD8 ABI2 ICE1 RGPD5

3.40e-0594795int:FGFR1OP2
InteractionAHNAK interactions

MYH9 TRIM25 FN1 ACSM5 RICTOR FBXO32 DMD PLOD1

3.47e-05318798int:AHNAK
InteractionACTG1 interactions

MYH9 ABI1 FN1 ABI2 MORF4L1 LARS1 RICTOR CHD3 FBXO32 MAPK6

3.50e-055207910int:ACTG1
InteractionTRAF3IP1 interactions

IL13RA1 KRT10 MYH9 ABI2 DMD

3.77e-0596795int:TRAF3IP1
InteractionMAP4 interactions

FN1 PRPF4 LARS1 RICTOR RO60 FBXO32 HERC2 MAPK6

3.96e-05324798int:MAP4
InteractionATAD3A interactions

DPP4 TRIM25 FN1 LARS1 RICTOR CHD3 FBXO32 MAPK6

4.51e-05330798int:ATAD3A
InteractionNPIPB6 interactions

RGPD8 RGPD1 RGPD5

4.53e-0518793int:NPIPB6
InteractionIGHV3-7 interactions

IGHV3-7 SMURF1

4.54e-053792int:IGHV3-7
InteractionVDAC2 interactions

DPP4 FN1 JAGN1 SMURF1 RICTOR CHD3 HERC2 MAPK6 PLOD1

4.80e-05432799int:VDAC2
InteractionEEF1D interactions

KRT10 MYH9 TRIM25 FN1 KDM4C SMURF1 RICTOR UPF1

4.81e-05333798int:EEF1D
InteractionMIRLET7A3 interactions

TRIM25 LARS1 CSTF3 UPF1 PLOD1

5.04e-05102795int:MIRLET7A3
InteractionEIF3B interactions

FN1 SMURF1 RICTOR CHD3 UPF1 FBXO32 HERC2 DHX29

5.23e-05337798int:EIF3B
InteractionNCKAP1L interactions

ABI1 ABI2 RICTOR

6.30e-0520793int:NCKAP1L
InteractionNDFIP2 interactions

TRIM25 TMEM245 SMURF1 IL2RG

6.88e-0556794int:NDFIP2
InteractionGAPDH interactions

DPP4 DPYD MYH9 TRIM25 FN1 CSTF3 RICTOR RO60 CHD3 FBXO32 HERC2

7.23e-056867911int:GAPDH
InteractionMYH10 interactions

DPP4 MYH9 TRIM25 FN1 MYH14 RICTOR CHD3 HERC2

8.14e-05359798int:MYH10
InteractionADRM1 interactions

MYH9 TRIM25 PRPF4 SMURF1 RO60 FBXO32 MAPK6

8.32e-05266797int:ADRM1
InteractionKCTD13 interactions

KRT10 MYH9 SORBS2 ABI1 TRIM25 FN1 TRIO KALRN MYH14 LARS1 SMURF1 CHD3 ACTN2 UPF1 DMD DHX29

8.50e-0513947916int:KCTD13
InteractionKRT10 interactions

DPP4 KRT10 FN1 RICTOR CHD3 MAPK6

9.34e-05187796int:KRT10
InteractionMETTL2B interactions

FBXO32 METTL2A METTL2B

9.70e-0523793int:METTL2B
InteractionMETTL2A interactions

MAPK6 METTL2A METTL2B

9.70e-0523793int:METTL2A
InteractionEEF2 interactions

TRIM25 FN1 KDM4C MYH14 LARS1 SMURF1 RICTOR UPF1 FBXO32 DHX29

9.77e-055887910int:EEF2
InteractionRAB10 interactions

DPP4 TRIM25 FN1 SMURF1 CHD3 DUSP22

1.02e-04190796int:RAB10
InteractionKRT14 interactions

DPP4 ABI2 RICTOR CHD3 FBXO32 KRT79

1.08e-04192796int:KRT14
InteractionSNRNP70 interactions

MYH9 TRIM25 FN1 PRPF4 SMURF1 CSTF3 RO60 CHD3 UPF1 FBXO32 PLOD1 DHX29 SCAF4

1.09e-049847913int:SNRNP70
InteractionTAOK3 interactions

DPP4 TRIM25 CTR9 SMURF1

1.16e-0464794int:TAOK3
InteractionKRT19 interactions

DPP4 KRT10 FN1 ABI2 CHD3 DMD KRT79

1.20e-04282797int:KRT19
InteractionNXF2 interactions

RGPD8 RICTOR UPF1 RGPD5

1.23e-0465794int:NXF2
InteractionKRT16 interactions

KRT10 FN1 RICTOR CHD3 MAPK6 KRT79

1.24e-04197796int:KRT16
InteractionHDAC2 interactions

ACSL3 KRT10 MYH9 SORBS2 TRIM25 TRIO PRPF4 MORF4L1 LARS1 CHD3 HERC2 DMD

1.31e-048657912int:HDAC2
InteractionRCC1 interactions

TRIM25 FN1 RGPD8 KDM4C RGPD1 RGPD5

1.39e-04201796int:RCC1
InteractionRUVBL2 interactions

MYH9 FN1 PRPF4 CTR9 MORF4L1 LARS1 PON2 RICTOR RO60 UPF1

1.43e-046167910int:RUVBL2
InteractionALB interactions

KRT10 MYH9 FN1 RICTOR CHD3 FBXO32 DMD MAPK6

1.47e-04391798int:ALB
InteractionDCUN1D4 interactions

TRIM25 RICTOR ITIH2

1.58e-0427793int:DCUN1D4
InteractionHNRNPA2B1 interactions

DPP4 TRIM25 FN1 SMURF1 PON2 RICTOR RO60 CHD3 UPF1 FBXO32 PLOD1

1.66e-047547911int:HNRNPA2B1
InteractionKIF23 interactions

ACSL3 MYH9 UTP15 MYH14 UBTF CENPI LARS1 ASPM RICTOR CHD3 UPF1 DMD TNFRSF21

1.73e-0410317913int:KIF23
InteractionELOF1 interactions

TRIO CTR9 SMURF1 MAPK6

1.74e-0471794int:ELOF1
InteractionTMPO interactions

ACSL3 MYH9 MYH14 UBTF LARS1 RGPD1 SMURF1 NFXL1 RICTOR CHD3 MAPK6

1.82e-047627911int:TMPO
InteractionVCL interactions

MYH9 SORBS2 TRIM25 FN1 ABI2 FBXO32 SCAF4

1.94e-04305797int:VCL
InteractionLDB3 interactions

ACTN2 FBXO32 DMD

1.97e-0429793int:LDB3
InteractionMYOZ3 interactions

ABI2 ACTN2 MAPK6 MORN3

2.04e-0474794int:MYOZ3
InteractionMIR98 interactions

TRIM25 LARS1 UPF1 PLOD1

2.50e-0478794int:MIR98
InteractionMIR206 interactions

TRIM25 LARS1 UPF1 PLOD1

2.63e-0479794int:MIR206
InteractionEPB41 interactions

MYH9 TRIM25 FN1 KDM4C RICTOR

2.64e-04145795int:EPB41
InteractionPRELP interactions

FRAS1 FN1 PON2

2.65e-0432793int:PRELP
InteractionSRP9 interactions

DPP4 UTP15 CTR9 LARS1 SMURF1 ACTN2 UPF1 DHX29

2.67e-04427798int:SRP9
InteractionBTF3 interactions

KRT10 MYH9 ABI1 TRIM25 RGPD8 MYH14 UBTF UPF1 HERC2 DHX29 RGPD5

2.74e-047997911int:BTF3
InteractionELL interactions

TRIM25 CTR9 ASPM ICE1

2.76e-0480794int:ELL
InteractionVIM interactions

KRT10 MYH9 FN1 KDM4C UBTF LARS1 SMURF1 RICTOR CHD3 FBXO32 MAPK6

2.89e-048047911int:VIM
InteractionNXPH2 interactions

FRAS1 ADGRV1 ITIH2

2.91e-0433793int:NXPH2
InteractionETV5 interactions

TRIM25 MYH14 CHD3

2.91e-0433793int:ETV5
InteractionCUEDC1 interactions

TRIM25 ABI2 SMURF1 DUSP22

3.03e-0482794int:CUEDC1
InteractionAPOLD1 interactions

TRIM25 FN1

3.15e-047792int:APOLD1
InteractionNUPR1 interactions

MYH9 TRIM25 UTP15 PRPF4 CTR9 UBTF MORF4L1 CSTF3 UPF1 PLOD1

3.27e-046837910int:NUPR1
InteractionKRT8 interactions

DPP4 KRT10 MYH9 FN1 RICTOR CHD3 DMD KRT79

3.31e-04441798int:KRT8
InteractionDLGAP4 interactions

SORBS2 TRIM25 ABI2 PLOD1

3.33e-0484794int:DLGAP4
InteractionB4GALT1 interactions

TRIM25 UBE2Q1 PON2 RICTOR

3.33e-0484794int:B4GALT1
InteractionTUBB4B interactions

MYH9 ABI1 TRIM25 FN1 SMURF1 NFXL1 RICTOR CHD3 HERC2

3.38e-04560799int:TUBB4B
InteractionKRT1 interactions

DPP4 KRT10 FN1 RICTOR CHD3 FBXO32

3.45e-04238796int:KRT1
InteractionU2AF1 interactions

RGPD2 FN1 PRPF4 SMURF1 CHD3 HERC2

3.53e-04239796int:U2AF1
InteractionECPAS interactions

DPP4 FN1 UBE2Q1 LARS1 ICE1 MAPK6 DHX29

3.55e-04337797int:ECPAS
InteractionAKAP8L interactions

DPP4 TRIM25 ABI2 SMURF1 CHD3 MAPK6

3.61e-04240796int:AKAP8L
InteractionACTN1 interactions

DPP4 MYH9 SORBS2 TRIM25 SMURF1 RICTOR ACTN2

3.81e-04341797int:ACTN1
InteractionUBASH3B interactions

KRT10 MYH9 TRIM25 KRT79 TXK

3.81e-04157795int:UBASH3B
InteractionTMOD3 interactions

DPP4 MYH9 TRIM25 PRPF4 LARS1 RICTOR

3.85e-04243796int:TMOD3
InteractionPABPC1 interactions

TRIM25 FN1 CTR9 LARS1 CSTF3 RO60 CHD3 UPF1 HERC2 PLOD1

3.93e-046997910int:PABPC1
InteractionRUVBL1 interactions

MYH9 PRPF4 MYH14 CTR9 MORF4L1 RICTOR RO60 CHD3 UPF1

4.10e-04575799int:RUVBL1
InteractionRAD18 interactions

ACSL3 MYH9 PRPF4 MYH14 CTR9 LARS1 RO60 SCAF4

4.20e-04457798int:RAD18
InteractionLMNA interactions

ACSL3 MYH9 TRIM25 FN1 UBE2Q1 JAGN1 CTR9 UBTF MORF4L1 SMURF1 RICTOR CHD3 HERC2 CA5A

4.32e-0412867914int:LMNA
InteractionMIR221 interactions

TRIM25 LARS1 UPF1 PLOD1

4.33e-0490794int:MIR221
InteractionMIR92A2 interactions

TRIM25 LARS1 CSTF3 UPF1

4.33e-0490794int:MIR92A2
InteractionHNRNPA0 interactions

DPP4 TRIM25 FN1 SMURF1 CHD3 UPF1 MAPK6

4.38e-04349797int:HNRNPA0
InteractionOAZ1 interactions

TRIM25 PGM2L1 UPF1

4.43e-0438793int:OAZ1
InteractionCIT interactions

ACSL3 MYH9 SORBS2 KALRN UTP15 PRPF4 MYH14 CTR9 UBTF CSTF3 RO60 CHD3 ACTN2 ADGRV1 PLOD1

4.51e-0414507915int:CIT
InteractionMYCBP2 interactions

SORBS2 TRIM25 RGPD8 UPF1 HERC2 MAPK6 UNC79

4.85e-04355797int:MYCBP2
InteractionEIF3A interactions

MYH9 FN1 SMURF1 RICTOR CHD3 UPF1 HERC2

4.85e-04355797int:EIF3A
InteractionHIP1 interactions

MYH9 TRIM25 SMURF1 MAPK6

4.90e-0493794int:HIP1
InteractionPCMT1 interactions

DPP4 ABI1 TRIM25 FN1 ABI2 CHD3

5.08e-04256796int:PCMT1
Cytoband1q31

ASPM RO60

5.03e-04198021q31
Cytoband4p12

NFXL1 TXK

5.58e-04208024p12
CytobandEnsembl 112 genes in cytogenetic band chr4p12

NFXL1 TXK

9.48e-0426802chr4p12
Cytoband17q23.2

TRIM25 METTL2A

1.53e-033380217q23.2
GeneFamilyTetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome

RGPD2 RGPD8 CTR9 RGPD1 RGPD5

2.81e-05115565769
GeneFamilyMyosin heavy chains

MYH9 MYH14

9.64e-04155621098
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

TRIO KALRN VAV3

1.12e-0366563722
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

HERC2 DMD

1.40e-031856291
GeneFamilyAcyl-CoA synthetase family

ACSL3 ACSM5

2.92e-032656240
GeneFamilyMethyltransferase like

METTL2A METTL2B

4.68e-0333562963
CoexpressionDUTERTRE_ESTRADIOL_RESPONSE_24HR_DN

CREBRF ACSL3 IL13RA1 FRAS1 MYH9 FN1 PGM2L1 FBXO32 ADGRV1 TNFRSF21 ITGB8

3.78e-075048011M2157
CoexpressionGSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP

GXYLT2 IL13RA1 DPYD ABI1 SMURF1 ITGB8

9.75e-06160806M6863
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_IN_TADS

POMT2 ACSL3 GXYLT2 MYH9 TRIO MYH14 CTR9 PON2 HERC2 MAPK6 TNFRSF21 SNX29 ITGB8

1.09e-0510098013M157
CoexpressionIIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP

FN1 RGPD8 DMD

1.21e-0515803M2152
CoexpressionWANG_LMO4_TARGETS_DN

ACSL3 CCDC83 KALRN MYH14 LARS1 RICTOR DMD MAPK6

1.47e-05361808M12674
CoexpressionGSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN

SLC9C1 MYH9 TRIM25 RICTOR SNX29 DMXL1

2.09e-05183806M8189
CoexpressionGSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP

HHLA2 GRK3 KDM4C UBTF NFXL1 PLOD1

3.16e-05197806M6165
CoexpressionGSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN

HHLA2 CCDC83 FN1 TRIO JAGN1 PON2

3.25e-05198806M9057
CoexpressionWANG_SMARCE1_TARGETS_UP

IL13RA1 DPYD FRAS1 FN1 PGM2L1 FBXO32 ITGB8

3.28e-05294807M1804
CoexpressionFOSTER_TOLERANT_MACROPHAGE_DN

RGPD2 IL13RA1 GRK3 RGPD8 PRPF4 RGPD1 NFXL1 ITGB8

5.51e-05435808MM1221
CoexpressionAtlasMESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05

DPP4 IL13RA1 MMP24 FRAS1 MYH9 FN1 MYH14 PON2 PGM2L1 IL2RG TNFRSF21 ITIH2

2.33e-057617912PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000

DPP4 DPYD SORBS2 GRK3 TRIO UBTF ASPM RO60 FBXO32 PLOD1 ITGB8 DMXL1

3.36e-057907912gudmap_developingGonad_e16.5_epididymis_1000
ToppCellpdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

DPP4 SORBS2 TMEM245 DMD ITIH2 CA5A

1.04e-061858061d874608aa2062024323512f68889219471b2f00
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DPP4 FRAS1 MYH14 PON2 PGM2L1 ITGB8

1.18e-06189806aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DPP4 FRAS1 MYH14 PON2 PGM2L1 ITGB8

1.18e-061898068977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

DPYD TRIO KDM4C SMURF1 ADGRV1 DMD

1.54e-061988061996373bdccc55aac347d349bd22f6aad6d0c668
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 UBE2Q1 KALRN SMURF1

1.31e-05168805e979a4fbeb9f21048b47d69e6da75c57650697f2
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DPP4 GRK3 MAPK6 DMXL1 MORN3

1.83e-05180805a682a5d55c612709c9ee9fa4289d6f8bef7fe1af
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

FN1 KALRN ACTN2 FBXO32 DMD

1.83e-05180805d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FRAS1 VAV3 ADGRV1 SNX29 ITGB8

1.88e-051818059d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCellCOVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type

SLC9C1 MYH9 SORBS2 ACTN2 DMD

1.93e-05182805287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FRAS1 VAV3 ADGRV1 SNX29 ITGB8

1.93e-05182805eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRAS1 KALRN ADGRV1 DMD UNC79

2.03e-051848052cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRAS1 KALRN ADGRV1 DMD UNC79

2.03e-05184805ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRAS1 KALRN ADGRV1 DMD UNC79

2.03e-051848052b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DPP4 FRAS1 VAV3 ADGRV1 ITGB8

2.20e-05187805c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DPP4 FRAS1 VAV3 ADGRV1 ITGB8

2.37e-051908051cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

DPP4 FRAS1 SORBS2 VAV3 ADGRV1

2.37e-05190805625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DPP4 FRAS1 VAV3 ADGRV1 ITGB8

2.37e-0519080559bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCellEpithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor

SLC9C1 MYH14 TMEM245 PON2 ADGRV1

2.43e-05191805d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCellnucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DPYD RGPD8 TRIO KDM4C SNX29

2.55e-05193805779276e775cb2492e8dd36436295a536084a6415
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ACSL3 TRIO PON2 VAV3 ITGB8

2.62e-0519480568d15917ae222cba0ad9e716d29eebb6c5f00f69
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ACSL3 DPP4 TRIO ABI2 ITGB8

2.62e-051948058b81f039f5b25d35a4d5a41b27d4d9360ba22f15
ToppCellRA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

FRAS1 MYH9 SORBS2 ACTN2 DMD

2.62e-0519480589812fb164065041357bb37a3c2d87028ec3de4e
ToppCellTCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9

DPP4 IL13RA1 FN1 PON2 TNFRSF21

2.62e-05194805b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DPP4 TRIO MYH14 PGM2L1 ITGB8

2.68e-05195805938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DPP4 TRIO MYH14 PGM2L1 ITGB8

2.68e-05195805d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

DPYD KDM4C SMURF1 ADGRV1 DMD

2.75e-05196805ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

GXYLT2 QRFPR KALRN ACTN2 FBXO32

2.75e-051968059830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

MYH9 SORBS2 ACTN2 FBXO32 DMD

2.82e-0519780571367bebc23d0e81f60f780d6b0ab3a1783ac014
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

MYH9 SORBS2 ACTN2 FBXO32 DMD

2.82e-051978050f9836554ace3f9d155ebafdd719aa26466ca44e
ToppCell367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

FN1 PGM2L1 CHD3 FBXO32 PLOD1

2.89e-05198805c55608633f66e3d434c5d81324efb07c5120d2c2
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SORBS2 FN1 RUNDC3B PON2 HERC2

2.89e-051988050a4626b51ba8b52acbaf616f0ced850079cd7149
ToppCell367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

FN1 PGM2L1 CHD3 FBXO32 PLOD1

2.89e-051988053e5459038fc6ed95f529eb4d1dc5113e16c19012
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-Neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type.

DPP4 SORBS2 CSTF3 ADGRV1 TNFRSF21

2.89e-0519880590ebefc9ba8dc2a81471e5693384f5ce56f06298
ToppCellmetastatic_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass

CREBRF FRAS1 ACTN2 UNC79

1.12e-04138804b2ab273f3e62f169b3b9cb82342e6617af99f582
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

POMT2 LRRC34 IGHV3-7 DMD

1.12e-0413880476be06136c83c167cedece7515228ed4d29dd1f0
ToppCellLA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper

MYH9 SORBS2 ACTN2 DMD

1.43e-041478048970eb6b82589f39439c61a57d999661ec8342de
ToppCellMild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

GRK3 VAV3 SNX29 RGPD5

1.46e-04148804dd5e1bc02824e743e1c030a303e32f27a359a8ca
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

DPP4 FN1 IL2RG CA5A

1.50e-04149804d9c47f523c75ddcd6131e45d2ffc24b970932cae
ToppCell368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|368C / Donor, Lineage, Cell class and subclass (all cells)

DPP4 FBXO32 IL2RG RGPD5

1.58e-0415180472c47ed207951e73ef6c72085b2a3f48a99be952
ToppCell368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells)

TRIM25 KDM4C MYH14 SNX29

1.79e-0415680425b0936960be4955b6a6d6b8a867fdd4be548f05
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RUNDC3B ACTN2 IL2RG TXK

1.79e-041568040bd32876413f3308f838f266e8c39ea0937ce5b9
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRIM25 GRK3 CENPI CHD3

1.97e-041608045d8d97c3da5837ba5fe743d2f8438f5cb7cea64b
ToppCellprimary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TRIM25 FN1 IL2RG CA5A

2.02e-04161804a60ef3f390f56bb05b687b17986fe6382f69f260
ToppCellprimary_visual_cortex-Non-neuronal-endothelial_cell-Endo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TRIM25 FN1 IL2RG CA5A

2.07e-041628040bdb1e5ba33e162bec1acb28256c1405a7658ee5
ToppCellprimary_visual_cortex-Non-neuronal-endothelial_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TRIM25 FN1 IL2RG CA5A

2.07e-041628045799a602ef8d83925907e8e34532428be7330228
ToppCellfacs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 RO60 ACTN2 DHX29

2.12e-04163804132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCellfrontal_cortex-Non-neuronal-endothelial_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TRIM25 FN1 IL2RG CA5A

2.17e-041648046a41a159134e605b80d5e731f9ed5bc803bb531b
ToppCellfrontal_cortex-Non-neuronal-endothelial_cell-Endo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TRIM25 FN1 IL2RG CA5A

2.17e-04164804ec68954fc09b6850273b5e59caa6b09d02151097
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 FN1 DUSP22

2.22e-0416580411227bff52eed30b80937fdb1968d0b8e6d30365
ToppCellCerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32

DPP4 FN1 IL2RG CA5A

2.22e-041658047d319a112b9062efee428bef6f4534d2ce782e04
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 FN1 DUSP22

2.22e-04165804036f9749048e5e50769cc3210339bf4da469215d
ToppCellfrontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TRIM25 FN1 IL2RG CA5A

2.27e-0416680427af6c906cff1d40d134f0386db7708869691121
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32

ABI1 KALRN ABI2 PGM2L1

2.38e-041688046db453cbbbaf4144a86fadcfa5805d33396713b5
ToppCellControl|World / group, cell type (main and fine annotations)

SLC9C1 SORBS2 MYH14 ADGRV1

2.38e-04168804a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCelldroplet-Spleen-SPLEEN-1m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 FN1 TNFRSF21

2.38e-04168804f3b7a7df54988de77dcc7066e2fc1feb9c280b13
ToppCelldroplet-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 FN1 TNFRSF21

2.43e-0416980491cfff1ad559cc327c6bb71c98aa29f0b3642568
ToppCelldroplet-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 FN1 TNFRSF21

2.43e-041698048e5e513090e86ca29fb61dfd388014774c506914
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-4_RORB_FOLH1B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DPP4 QRFPR VAV3 TXK

2.43e-0416980428aa6b64e88ba0320991ae6788012d904e2a4a78
ToppCelldroplet-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 FN1 TNFRSF21

2.43e-04169804972618e684321060c7af2429f853a6d639e8aae8
ToppCellP15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DPYD KRT10 FN1 ADGRV1

2.49e-04170804ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

GXYLT2 QRFPR FN1 ACTN2

2.49e-041708047fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCellCOVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

SORBS2 GRK3 VAV3 ACTN2

2.49e-041708044232fe937909f93d3736988c707b8f95ce993398
ToppCelldroplet-Spleen-SPLEEN-1m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 FN1 TNFRSF21

2.49e-041708047cb7ad9ab064b6ea452545d145e5b1d4090cd4c1
ToppCelldroplet-Spleen-SPLEEN-1m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 GRK3 FN1 TNFRSF21

2.49e-04170804db7cee7e518debb2cbe9eeae05d47e14b69cb8e3
ToppCelldroplet-Lung-21m-Hematologic-myeloid|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IL13RA1 GRK3 FN1 TNFRSF21

2.54e-0417180422ad6de44e1d3f72a3d78d46fd26a5743a4f84a5
ToppCellControl-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

MYH9 GRK3 RGPD1 ICE1

2.54e-04171804d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TRBV16 ACTN2 IL2RG TXK

2.54e-04171804801893c318f7b1abc8d97bac86a00974f910a71c
ToppCelldroplet-Lung-nan-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 FN1 TNFRSF21 DUSP22

2.60e-0417280435d09640d5b04fa0bbb1b40d4b8f97da587a5046
ToppCelldroplet-Lung-nan-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL13RA1 FN1 TNFRSF21 DUSP22

2.60e-0417280498cb64e2a768908105701a7a5b58f336036250fd
ToppCelldroplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRK3 FN1 DUSP22 CA5A

2.66e-041738046d2ceba4f89a228600e2b40aba81bb0eb81578c0
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

KALRN ACTN2 FBXO32 DMD

2.66e-04173804cb6389536195443633adb06e5f1b7483530773d1
ToppCell15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class

FN1 ASPM CHD3 PLOD1

2.72e-04174804fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCellPND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LRRC34 SORBS2 ITIH2 MORN3

2.72e-04174804179a52d77899a929396b98d4ab2c270dd2ec708e
ToppCellPND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LRRC34 SORBS2 ITIH2 MORN3

2.72e-041748049165a1094d345328e58962f4b2a20334c3e93ead
ToppCellFrontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

FRAS1 KALRN ABI2 PGM2L1

2.78e-04175804ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f
ToppCell3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RGPD2 IGHV3-7 IL2RG DUSP22

2.78e-04175804c3d3f11602379aaba65842a98835299e54fccd84
ToppCellfacs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

QRFPR DPYD FRAS1 ADGRV1

2.78e-04175804887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCellFrontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

FRAS1 KALRN ABI2 PGM2L1

2.78e-0417580421f8f11a8b874d4f7c47931010a2535f2a5a3373
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DPYD ACTN2 DMD ITGB8

2.84e-041768040710689e66deba179b0a8038cdd56b4834984f12
ToppCellpdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

DPP4 SORBS2 DMD CA5A

2.84e-041768041e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCelldroplet-Kidney-nan-21m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RUNDC3B ACTN2 IL2RG TXK

2.84e-04176804feafc757e7aa4f17128ff34886beb2fd3461c9ea
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9

GXYLT2 DPP4 FN1 PON2

2.84e-041768040923b01137d6f9956ca815b41102c81e82624065
ToppCellCOVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC9C1 SORBS2 ACTN2 DMD

2.84e-041768049df7a124ebafb0087da0cda133a394275d7bed81
ToppCelldroplet-Bladder-nan-24m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RUNDC3B ACTN2 IL2RG TXK

2.84e-041768040089b50d607f4d2f18639fab0f3fc779227baa7a
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

GRK3 MAPK6 DMXL1 MORN3

2.90e-0417780436b5d29caa9cffbc0284f771a4db71aa72171a89
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD3 ACTN2 IL2RG TXK

2.90e-041778046d86b2f97426b552dff5ce6ddf0ead1285ed618e
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PGM2L1 ACTN2 IL2RG TXK

2.90e-041778049d2d70d53b919fed3328812889a55e5e1a0759de
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TRBV16 ACTN2 IL2RG TXK

2.90e-04177804c840efec4eba746543eac0f48dd688518f0fb5f0
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD3 ACTN2 IL2RG TXK

2.90e-04177804d8b1bbc224d062a57a6ad40b4b2af5d6e0fe63b3
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DPYD ACTN2 DMD ITGB8

2.96e-041788046f61490d79cd1727ed2d5cc673823dd4efdafac1
ToppCellPBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters

DPP4 LRRC34 KALRN DMD

2.96e-041788040667abc05eb2254710b9c648c65b7cfdfe7831b7
ToppCellImmune_cells-T_cells|Immune_cells / Lineage and Cell class

CHD3 ACTN2 IL2RG TXK

2.96e-04178804af420242277e2a4e2524002a2914b0538f79a134
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CHD3 ACTN2 IL2RG TXK

2.96e-0417880428bb1e3e447261d0cb47e2b6343b17b2d74db525
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH14 UPF1 ADGRV1 ITGB8

3.03e-041798046e965e424eebef50f0202cff75f458be395cfca1
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

QRFPR SLC9C1 FBXO32 DMD

3.03e-0417980402c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell(3)_Chondrocytes-(32)_Chondro-prehyper-2|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis

CREBRF GXYLT2 DPYD VAV3

3.09e-04180804708a5c89b9337e281fce4f482892a1c1766c7812
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ACSL3 FN1 TRIO KALRN

3.22e-04182804ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

DPP4 CHD3 FBXO32 TXK

3.29e-04183804f2ef110bf29b1a8276ef216238363e542db262c1
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ASPM ACTN2 DMD ITGB8

3.36e-04184804ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428
ToppCellPCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

MYH14 VAV3 ADGRV1 TXK

3.36e-04184804fa4915b0498f3069fd5ef497286445528f75187e
Diseaseglycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement

RGPD1 TXK

1.81e-048762EFO_0800533
Diseasealcohol and nicotine codependence

RGPD2 RGPD1

5.01e-0413762EFO_0004776
Diseaseactinic keratosis

MMP24 HERC2

5.84e-0414762EFO_0002496
Diseaseesophagus squamous cell carcinoma (is_marker_for)

DPP4 KDM4C RICTOR

9.33e-0474763DOID:3748 (is_marker_for)
Diseasecomplement factor H-related protein 3 measurement

KALRN ASPM ADGRV1 DMD

9.67e-04169764EFO_0600056
Diseaseskin sensitivity to sun

HERC2 DUSP22

1.09e-0319762EFO_0004795
Diseaseblood arsenic measurement

SORBS2 PLOD1

1.09e-0319762EFO_0021527
DiseaseNeutropenia

DPYD JAGN1

1.33e-0321762C0027947
Diseasenevus count, cutaneous melanoma

LRRC34 ADGRV1 HERC2

1.70e-0391763EFO_0000389, EFO_0004632
Diseaseresponse to norepinephrine-dopamine reuptake inhibitor

FBXO32 ADGRV1

2.04e-0326762EFO_0007870
Diseaseputamen volume change measurement, age at assessment

TMEM245 VAV3

2.20e-0327762EFO_0008007, EFO_0021495
DiseaseSezary Syndrome

CHD3 IL2RG

2.20e-0327762C0036920
DiseaseHyalinosis, Segmental Glomerular

MYH9 FN1

2.37e-0328762C0086432
Diseasesuntan

MMP24 HERC2 DUSP22

2.41e-03103763EFO_0004279
DiseaseAutosomal dominant nonsyndromic hearing loss

MYH9 MYH14

2.54e-0329762cv:C5779548

Protein segments in the cluster

PeptideGeneStartEntry
SFFKGVDWQHVYLQK

GRK3

451

P35626
WAYGKEQILLQKDYE

ACTN2

416

P35609
YEANKVKLWGLNTEY

CREBRF

546

Q8IUR6
HAYQVKPQWKAYDDV

ADGRV1

6081

Q8WXG9
AIIYVIKKNDDGWYE

ABI1

471

Q8IZP0
EKWKHQTGVELYEGY

ACSM5

356

Q6NUN0
GKQASWYIHKYVQSQ

DPYD

496

Q12882
KALEISHQWYQYKRQ

DMD

1871

P11532
WKYQLYLHGLHKKSD

DSCR4

91

P56555
QTHGWLLYQEKIRYA

DHX29

1266

Q7Z478
DGGKLRYQLYHWLEK

DMXL1

2051

Q9Y485
WYRGIKITNHQHKEY

ASPM

2076

Q8IZT6
AIIYVIKKNDDGWYE

ABI2

476

Q9NYB9
YWEEYKNVGSERHAK

CCDC83

136

Q8IWF9
WHVQQLEIKYDFLYE

QRFPR

181

Q96P65
QLEYIGRSVHYWKKV

RGPD5

596

Q99666
QLEYIGRSVHYWKKV

RGPD8

596

O14715
KDKQVKYFIHYSGWN

MORF4L1

36

Q9UBU8
YALTGQKWRQKHITY

MMP24

156

Q9Y5R2
NYELEGKIKEWYEKH

KRT10

171

P13645
LAEVSNGLKKHYYWT

LRRC34

426

Q8IZ02
KVEAGHQWYLQVIYI

FRAS1

3811

Q86XX4
EVAVELSLWQKHKYY

NFXL1

876

Q6ZNB6
VQVHAWQLYYSKKLL

JAGN1

156

Q8N5M9
LHYQEVKWRKLGSYE

ITIH2

181

P19823
VHKYKWLKQNVQGLY

HERC2

1616

O95714
WVANIKQDGSEKYYV

IGHV3-7

66

P01780
WYQTKYEELQVTAGK

KRT79

336

Q5XKE5
VLHYAGKVDYKANEW

MYH14

596

Q7Z406
HYYEPKLIIDLSNWK

MAPK6

466

Q16659
HNRKEDNGYKVYWET

PGM2L1

176

Q6PCE3
LWRDYNKYEEGINIH

CSTF3

186

Q12996
LYQKYKNAITWGDQD

GXYLT2

301

A0PJZ3
GSEVVIHWKYQDSYK

HHLA2

56

Q9UM44
KDKIVFGNIHQIYDW

KALRN

1971

O60229
KQVDYEINAHKYWND

METTL2B

66

Q6P1Q9
YQLWKQGKDIYTIDH

KDM4C

331

Q9H3R0
GHKLAYVWNNDIYVK

DPP4

161

P27487
IHYAGKVDYKADEWL

MYH9

571

P35579
KQLEKWHREYNSKYV

RICTOR

826

Q6R327
DQNDDTLHWKKYDIY

IL13RA1

391

P78552
NPEDWKEKYIHQNYT

PLOD1

526

Q02809
KQVDYEINAHKYWND

METTL2A

66

Q96IZ6
KYLETYLNLHWANVV

PON2

191

Q15165
FAVQGKQFHWYKDLL

ITGB8

341

P26012
WNHLLNYYKEQKVLV

UPF1

896

Q92900
LVHWNSVKYQNYKEA

CA5A

156

P35218
DKWIKYRKGHANIAY

ICE1

2146

Q9Y2F5
KTYHVGEQWQKEYLG

FN1

2391

P02751
VDKKGNYHYLVKWRD

CHD3

641

Q12873
LHIWIALALEYYKQG

CTR9

41

Q6PD62
HEVHQYRQWLKEEYG

DUSP22

141

Q9NRW4
TLHYWYKNSDNDKVQ

IL2RG

86

P31785
IWYKVNNYEHGKEFT

CENPI

401

Q92674
QYFHQEKWIYVHKGS

FBXO32

76

Q969P5
LNKGIKADYKQYWDV

SCAF4

581

O95104
DYYVGEWKDNVKHGK

MORN3

36

Q6PF18
DQQEYIGRSVHYWKK

RGPD1

586

P0DJD0
LDTLLYRKHNKQWYE

RUNDC3B

371

Q96NL0
GEKITQDTLYWNNYK

UTP15

16

Q8TED0
FWYYVKEVLNKHELQ

SNX29

86

Q8TEQ0
KWIYYCNGHGIDILK

TNFRSF21

406

O75509
YLHKDYNNLWIIKKH

POMT2

376

Q9UKY4
LYHIPWLDKNKDYIN

SLC9C1

866

Q4G0N8
QEYIGRSVHYWKKVL

RGPD2

596

P0DJD1
KKSKEEYQQTWYHEG

PRPF4

156

O43172
YLDYGEENWKKQTSQ

LARS1

531

Q9P2J5
YITKGWKEVHELYKE

RO60

201

P10155
YILRKIDQNWYEGEH

SORBS2

891

O94875
KWNQHYDLYVGKTDS

SMURF1

61

Q9HCE7
KVILGQYNWLSYEDV

ACSL3

126

O95573
CYKKGIHYWEVELQK

TRIM25

506

Q14258
YQYGREWITHKLHKI

TMEM245

531

Q9H330
KITNLEIYEWYHRNI

TXK

141

P42681
KHYQIKKNDSGQWYV

TXK

201

P42681
TPQQLWYTHEKKVYL

UBTF

201

P17480
KGHSYVFWYQQVLKN

TRBV16

46

A0A087WV62
KDKIVFGNIHQIYDW

TRIO

2011

O75962
SYKSLVQIHEKNGWY

UBE2Q1

401

Q7Z7E8
KQEVWKDLLYVIAYG

UNC79

251

Q9P2D8
ENKKWSYGFYLIHTQ

VAV3

461

Q9UKW4